Diabetes -

1.	What Should be the Treatment of a Person with IGT/ Newly Diagnosed Diabetes who Fails Lifestyle Modifications?
•	Metformin
•	TZDs
•	Insulin
•	GLP1/DPP4
•	Combination therapy

2.	Changing the Treatment Paradigm of T2DM – Evidence from Ongoing Studies:
•	Early combination therapy
•	GLP-1/ DPP-IV inhibitors/pramlintide
•	Anti-inflammatory agents
•	"Diabetic Bariatric surgery"

3.	Use of Insulin in T2DM
•	Safety of inhaled insulin in T2DM
•	Comparison of different insulin regimens in T2DM based on evidence based medicine
•	Substitution of first phase insulin response in T2DM patient
•	When and how to intensify insulin treatment in T2DM

4.	What is the Best Means to Treat Fasting Hyperglycemia in T2DM?
•	Night-time long acting insulin/Premixed insulin
•	Oral agents that block gluconeogenesis
•	Novel agents – CB-1 antagonists, GLP 1 and DPP4 inhibitors, GK activators

5.	Glitazone / PPAR alpha/gama in Type 2 Diabetes
•	Pros
•	Cons

6.	Future Treatment / Cure of T1DM – What will bring the breakthrough?
•	Stem cell therapy
•	Islet cell transplantation
•	Closed-loop insulin delivery system (artificial pancreas)
•	Salvage of existing beta cells

7.	Therapy for LADA and for Protection of Beta Cell Function in T1DM diagnosed in Adult age
•	The natural history of beta cell function in LADA and in Type 1 diabetes diagnosed in adult age
•	LADA: sulphonylureas vs. metformin, vs. glitazones. vs. insulin: pros and cons for protection of beta cell function
•	Antigen specific therapy (GAD and Diapep277)
•	Immunomodulatory treatment (anti-CD3 and other agents)

8.	Multiple Events of Mild Hypoglycemia – A Price Worth Paying for Improved Glucose Control?
•	Pros
•	Cons

9.	Blood Glucose Self-Monitoring in Non Insulin Treated Patients is:
•	Good value and appropriately used in diabetes management
•	Too costly and inappropriately used in diabetes management

10.	Continuous Glucose Monitoring (CGM) - Who will benefit from it?
•	T1DM
•	T2DM
•	ICU setting
•	The place for advisory/auxiliary tools to improve diabetes control

11.	Intensive Glycemic Control in Hospitalized Patients/ICU – Is it mandatory and How?
•	Yes
•	No

12.	Role of Mitochondria in Aging and Diabetes
•	The muscle
•	The beta cell

13.	Novel Markers of Diabetes Control - What should be the Gold Standard?
•	HbA1c is still the best
•	Glucose variability as a target for intervention
•	Mean glucose and deviations